3.4.21.B42 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25123036&form=6&db=m KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15102682&form=6&db=m Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 beta-Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6336956&form=6&db=m Demonstration of kallikrein-like protease activity in nonactivated plasma of patients with Cooley's anemia. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,2,0 3.4.21.B42 Brain Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9895341&form=6&db=m Immunoreactivity, ultrastructural localization, and transcript expression of prostate-specific antigen in human neuroblastoma cell lines. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.21.B42 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17487371&form=6&db=m Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,4,1 3.4.21.B42 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18515984&form=6&db=m Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression. causal interaction,ongoing research,unassigned 3,4,0 3.4.21.B42 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25503118&form=6&db=m Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B? receptor in breast cancer cells. causal interaction,ongoing research,therapeutic application,unassigned 1,4,1,0 3.4.21.B42 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31983196&form=6&db=m Novel Biomarkers Aim at Detecting Metastatic Sentinel Lymph Nodes in Breast Cancer causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,1 3.4.21.B42 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31720087&form=6&db=m KLK11 suppresses cellular proliferation via inhibition of Wnt/?-catenin signaling pathway in esophageal squamous cell carcinoma. causal interaction,therapeutic application,unassigned 4,3,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11782391&form=6&db=m Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12845660&form=6&db=m Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. diagnostic usage,ongoing research,unassigned 4,2,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15102682&form=6&db=m Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17671125&form=6&db=m Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19184568&form=6&db=m Over-expression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,4,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21257721&form=6&db=m Pentraxin-3 is a Novel Biomarker of Lung Carcinoma. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26224476&form=6&db=m Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707153&form=6&db=m Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31720087&form=6&db=m KLK11 suppresses cellular proliferation via inhibition of Wnt/?-catenin signaling pathway in esophageal squamous cell carcinoma. causal interaction,therapeutic application,unassigned 4,3,0 3.4.21.B42 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33420975&form=6&db=m KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/?-catenin signaling. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,1 3.4.21.B42 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707153&form=6&db=m Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Carcinoma, Non-Small-Cell Lung http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25779361&form=6&db=m Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival? therapeutic application,unassigned 2,0 3.4.21.B42 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707153&form=6&db=m Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34059001&form=6&db=m KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy. causal interaction,ongoing research,unassigned 1,3,0 3.4.21.B42 Colonic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19367279&form=6&db=m The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. causal interaction,ongoing research,unassigned 2,3,0 3.4.21.B42 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25123036&form=6&db=m KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27882085&form=6&db=m Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer. causal interaction,ongoing research,therapeutic application,unassigned 4,4,1,0 3.4.21.B42 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29497313&form=6&db=m Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell. causal interaction,therapeutic application,unassigned 1,3,0 3.4.21.B42 Dermatitis, Atopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17518992&form=6&db=m Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. diagnostic usage,ongoing research,unassigned 4,4,0 3.4.21.B42 Dry Eye Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23086370&form=6&db=m Elevated Immunoglobulin to Tissue KLK11 in Patients With Sjögren Syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 3.4.21.B42 Esophageal Squamous Cell Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31720087&form=6&db=m KLK11 suppresses cellular proliferation via inhibition of Wnt/?-catenin signaling pathway in esophageal squamous cell carcinoma. causal interaction,therapeutic application,unassigned 4,3,0 3.4.21.B42 hippostasin deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31720087&form=6&db=m KLK11 suppresses cellular proliferation via inhibition of Wnt/?-catenin signaling pathway in esophageal squamous cell carcinoma. causal interaction,therapeutic application,unassigned 4,3,0 3.4.21.B42 Laryngeal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22429520&form=6&db=m Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. diagnostic usage,ongoing research,unassigned 4,4,0 3.4.21.B42 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16800740&form=6&db=m Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues. diagnostic usage,unassigned 4,0 3.4.21.B42 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16870045&form=6&db=m Decreased kallikrein 11 messenger RNA expression in lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,1 3.4.21.B42 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21257721&form=6&db=m Pentraxin-3 is a Novel Biomarker of Lung Carcinoma. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.21.B42 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25779361&form=6&db=m Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival? therapeutic application,unassigned 2,0 3.4.21.B42 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26224476&form=6&db=m Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.4.21.B42 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34067437&form=6&db=m Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.4.21.B42 Mesothelioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16540645&form=6&db=m Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction. causal interaction,diagnostic usage,unassigned 3,3,0 3.4.21.B42 Nasopharyngeal Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33015784&form=6&db=m Diagnostic and prognostic values of KLK11 in nasopharyngeal carcinoma. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,2,0 3.4.21.B42 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21618246&form=6&db=m Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 3.4.21.B42 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22969854&form=6&db=m Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors. diagnostic usage,unassigned 3,0 3.4.21.B42 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24510347&form=6&db=m The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer. diagnostic usage,unassigned 4,0 3.4.21.B42 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26224476&form=6&db=m Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.4.21.B42 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34067437&form=6&db=m Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.4.21.B42 Neoplasm, Residual http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29095848&form=6&db=m Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer. causal interaction,diagnostic usage,unassigned 4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12736044&form=6&db=m Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. causal interaction,diagnostic usage,unassigned 4,3,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15102682&form=6&db=m Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15893744&form=6&db=m Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,4 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17487371&form=6&db=m Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,4,1 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19242826&form=6&db=m Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,3 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21257721&form=6&db=m Pentraxin-3 is a Novel Biomarker of Lung Carcinoma. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21520985&form=6&db=m Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21618246&form=6&db=m Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21672088&form=6&db=m Normal prostate-derived stromal cells stimulate prostate cancer development. causal interaction,ongoing research,unassigned 1,3,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22429520&form=6&db=m Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. diagnostic usage,ongoing research,unassigned 4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22969854&form=6&db=m Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors. diagnostic usage,unassigned 3,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25123036&form=6&db=m KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26224476&form=6&db=m Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27882085&form=6&db=m Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer. causal interaction,ongoing research,therapeutic application,unassigned 4,4,1,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29874189&form=6&db=m Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by next-generation sequencing technology. therapeutic application,unassigned 4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30323977&form=6&db=m Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31611973&form=6&db=m Cancer-associated fibroblast stimulates cancer cell invasion in an interleukin-1 receptor (IL-1R)-dependent manner. causal interaction,unassigned 2,0 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31983196&form=6&db=m Novel Biomarkers Aim at Detecting Metastatic Sentinel Lymph Nodes in Breast Cancer causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,1 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33420975&form=6&db=m KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/?-catenin signaling. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,1 3.4.21.B42 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34067437&form=6&db=m Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.4.21.B42 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9895341&form=6&db=m Immunoreactivity, ultrastructural localization, and transcript expression of prostate-specific antigen in human neuroblastoma cell lines. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12727843&form=6&db=m Parallel overexpression of seven kallikrein genes in ovarian cancer. causal interaction,diagnostic usage,unassigned 3,1,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15102682&form=6&db=m Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15329323&form=6&db=m Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients. causal interaction,diagnostic usage,unassigned 2,4,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16467084&form=6&db=m Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. diagnostic usage,ongoing research,unassigned 4,4,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17671125&form=6&db=m Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29095848&form=6&db=m Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer. causal interaction,diagnostic usage,unassigned 4,4,0 3.4.21.B42 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30323977&form=6&db=m Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Pancreatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34439122&form=6&db=m Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,2,1 3.4.21.B42 Prostatic Hyperplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14559849&form=6&db=m The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. causal interaction,diagnostic usage,unassigned 4,4,0 3.4.21.B42 Prostatic Hyperplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16800741&form=6&db=m mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11550212&form=6&db=m Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12539228&form=6&db=m Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12736044&form=6&db=m Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. causal interaction,diagnostic usage,unassigned 4,3,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14559849&form=6&db=m The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. causal interaction,diagnostic usage,unassigned 4,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15893744&form=6&db=m Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,4 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16800741&form=6&db=m mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16800743&form=6&db=m Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network. diagnostic usage,therapeutic application,unassigned 3,1,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17905108&form=6&db=m Is there a role for serum human tissue kallikrein in detection of prostate cancer? diagnostic usage,ongoing research,unassigned 4,4,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19190824&form=6&db=m Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,1,0 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19242826&form=6&db=m Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,3 3.4.21.B42 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21520985&form=6&db=m Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.21.B42 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17459012&form=6&db=m Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 3.4.21.B42 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9456079&form=6&db=m Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. causal interaction,unassigned 2,0 3.4.21.B42 Squamous Cell Carcinoma of Head and Neck http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33420975&form=6&db=m KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/?-catenin signaling. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,1 3.4.21.B42 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21618246&form=6&db=m Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1